National Center for Liver Cancer;
Second Military Medical University;
Shanghai 200438;
China;
International Cooperation Laboratory on Signal Transduction;
Eastern Hepatobiliary Surgery Hospital;
Second Military Medical University;
Shanghai 200438;
China;
Center for Drug Safety Evaluation and Research;
State Key Laboratory of Drug Research;
Shanghai Institute of Materia Medica;
Chinese Academy of Sciences;
Shanghai 201203;
China;
Fudan University Shanghai Cancer Center;
Shanghai 200032;
China;
The Graduate School of Fujian Medical University;
Fuzhou 350122;
China;
Institute of Pathology;
Southwest Hospital;
Third Military Medical University(Army Medical University);
Chongqing 400038;
China;
Key Laboratory of Tumor Immunopathology;
Ministry of Education of China;
Chongqing 400038;
China;
China Military Institute of Chinese Materia;
Fifth Medical Center of Chinese PLA General Hospital;
Beijing 100039;
China;
Department of Health Statistics;
Faculty of Medical Service;
Second Military Medical University;
Shanghai 200438;
China;
Aristolochic acids(AAs); Mutational signature; AA-DNA adduct; Hepatocellular carcinoma(HCC); Liver tumorigenesis; Hepatitis B virus(HBV); Risk factors; Tumor prevention;